14 reports

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • SAGE THERAPEUTICS ENTERS INTO LICENSING AGREEMENT WITH LIGAND PHARMA
  • SAGE THERAPEUTICS AMENDS LICENSING AGREEMENT WITH CYDEX PHARMA

Summary Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system disorders.The company’s pipeline products include SAGE-547, SAGE-689 and SAGE-217. Its SAGE-547 is an intravenous formulation therapy combined with current...

  • Pharmaceutical
  • United States
  • Company
  • Company Operations
  • SAGE Therapeutics

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • SAGE THERAPEUTICS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2011 TO YTD 2017
  • SAGE THERAPEUTICS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2011 TO YTD 2017

Summary Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics and medicines for central nervous system disorders. The company’s pipeline products include SAGE-547, SAGE-689 and SAGE-217. Its SAGE-547 is an intravenous formulation therapy combined with...

  • Pharmaceutical
  • United States
  • World
  • Company Financials
  • SAGE Therapeutics
  • Products under Development by Companies, H2 2016
  • Status Epilepticus - Therapeutics under Development by Companies

Purdue Pharma L. P.

  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • SAGE Therapeutics
  • Products under Development by Companies, H1 2016
  • Status Epilepticus - Therapeutics under Development by Companies

In 2003, Marinus Pharmaceuticals has in-licensed Ganaxolone from Purdue Pharma.

  • Pharmaceutical
  • United States
  • Company Operations
  • Product Initiative
  • SAGE Therapeutics
  • Essential Tremor - Companies Involved in Therapeutics Development
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016

Merz Pharma GmbH & Co.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • SAGE Therapeutics
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd
  • Essential Tremor - Companies Involved in Therapeutics Development
  • ESSENTIAL TREMOR - PIPELINE BY SAGE THERAPEUTICS, INC., H1 2016

KGaA (Merz) is a pharmaceutical product distributor that offers pharmaceuticals, consumer products, writing instruments, and promotional items.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • SAGE Therapeutics
  • Sage Therapeutics, Inc., Key Facts
  • Sage Therapeutics, Inc. Overview

(Sage) is a pharmaceutical company that develops and commercializes therapeutics and medicines for central nervous system disorders.

  • Pharmaceutical
  • Therapy
  • United States
  • Company Operations
  • SAGE Therapeutics
  • CORPORATE VENTURING - DEAL REPORTS

Target Acquirer ## Acquirer ## Tesla Motors, Inc.

  • Pharmaceutical
  • China
  • Company
  • M&A
  • Tencent Holdings Ltd